Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-24-000008

Director sold 8,391 shares at $22.99 ($192,909)

  • Director acquired 17,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

FOUSE JACQUALYN A · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-01-05 Exercise or conversion : show line 1 in the form 10b5-1 +17,500 124,466 D
2024-01-09 Sale : show line 2 in the form 10b5-1 −8,391 $22.99 $192,909 116,075 D
Open-market sales · 8,391 sh · avg $22.99 · $192,909

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-01-05 Exercise or conversion : show line 3 in the form 10b5-1 Performance share units −17,500 0 D
Loading xslF345X05/wk-form4_1704835604.xml…